All News

From Julia Louis-Dreyfus opening up about her breast cancer experience to Dolph Lundgren discussing his experience, here’s what’s happening in the cancer space this week.

In this on-demand webinar series, CURE partnered with TOUCH, The Black Breast Cancer Alliance to offer resources for women of color with breast cancer that can help with emotional support throughout their journey.

In this on-demand webinar series, CURE partnered with TOUCH, The Black Breast Cancer Alliance to share ways patients can delegate tasks in order to take care of themselves during their cancer journey.

In this on-demand webinar series, CURE partnered with TOUCH, The Black Breast Cancer Alliance to offer advice and ways patients can seek support to ensure they are taking care of their mental and emotional health after a breast cancer diagnosis.

In this on-demand webinar series, CURE partnered with TOUCH, The Black Breast Cancer Alliance to offer background on what exactly resilience during breast cancer is.

In this on-demand webinar series, CURE partnered with TOUCH, The Black Breast Cancer Alliance to highlight the importance of having difficult conversations with one’s family about a breast cancer diagnosis and its treatment.

In this on-demand webinar series, CURE partnered with TOUCH, The Black Breast Cancer Alliance to discuss mental resilience during one’s breast cancer journey.

Laura Shinn and Jenna Cavalero, both former childhood patients of the Children’s Hospital of New Orleans, reflect on how their cancer journeys inform their work with patients today.

Information about gynecologic cancers found on TikTok may not be credible or reliable, according to findings from a recent study.

While there has been a slight improvement in the availability of platinum-based chemotherapy agents, most institutions are still facing shortages and “living paycheck to paycheck” with the drugs, a survey revealed.

Survivors of cervical cancer who engage in sexual activity or vaginal dilation after radiation could be at lower risk for developing long term side effects.

Braftovi (encorafenib) with Mektovi (binimetinib) has been approved for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) with a BRAF V600E mutation, the agency announced on Wednesday evening.

Adding BXCL701 to Keytruda tended to improve overall survival outcomes for patients with small cell neuroendocrine prostate cancer, according to phase 2 study results.

Findings from the CheckMate 649 trial “further support the use of (Opdivo) plus chemotherapy as a tolerable and efficacious first-line treatment” for some patients, according to researchers.

Exercise can help empower patients with cancer and boost their overall health, though on difficult days, it is equally important that patients give themselves grace, an expert said.

I embarked on my journey as a patient advocate for individuals with hereditary cancer syndromes after experiencing the underestimated consequences of prophylactic measures meant to prevent gynecological cancers.

Using antidepressants after receiving a diagnosis of liver cancer may lower overall and cancer-specific mortality rates, according to recent research.

The overexpression of the gene, BRD4, may be the cause of chemotherapy resistance in patients with high-grade serous ovarian cancer, according to research.

A recent phase 3 trial revealed that the primary endpoint was met with Keytruda for patients with localized muscle-invasive urothelial carcinoma and locally advanced urothelial carcinoma.

Measuring cancer DNA in the blood may give clinicians a better idea of which patients with lung cancer need their immunotherapy treatment altered.

Efforts are being made to curb the ongoing chemotherapy shortage, and while things have gotten better, there is still more work to do.

A local art exhibit allowed expressive creativity on a unique canvas to raise breast cancer awareness.

A diagnosis of a rare internal form of melanoma left J.B. Ward and her care team in “a whirlwind of confusion,” but she pushed for aggressive forms of treatment.

In the recent AUGMENT-101 trial, revumenib met the study goals of complete remission in patients with acute myeloid leukemia or acute lymphoid leukemia.

After discussions with the FDA, Takeda plans on voluntarily withdrawing Exkivity as a treatment for adults with EGFR exon 20 insertion mutation-positive, locally advanced or metastatic non-small cell lung cancer.

Research found that skipping some counseling for genetic cancer testing did not increase distress, which may lead to beneficial remote options.

I’ve been having a wonderful (well…maybe challenging is the right word) growing season this past year, learning how to be a better collaborator.